Sommers D K, van Wyk M, Snyman J R
Department of Pharmacology, University of Pretoria, South Africa.
Eur J Clin Pharmacol. 1994;46(6):569-71. doi: 10.1007/BF00196119.
The effect of the nonsteroidal anti-inflammatory drug, tenoxicam, on diazoxide-induced lowering of standing diastolic blood pressure was explored in 10 normal volunteers. With diazoxide there was a significant fall in the 5-min standing diastolic pressure, i.e. a median drop of 15.5, 11.0, 9.5 and 7.0 mm Hg at 10, 35, 75 and 105 min, respectively, but with the tenoxicam-diazoxide regimen this pressure did not differ significantly from baseline at any time point. Tenoxicam did not modify the diazoxide-induced changes in blood glucose and plasma insulin. It may be that prostaglandins normally contribute to the lowering of peripheral vascular resistance, or that acutely-administered diazoxide enhances the release of vasodilatory prostaglandins.
在10名正常志愿者中探究了非甾体抗炎药替诺昔康对二氮嗪引起的站立位舒张压降低的影响。使用二氮嗪后,5分钟站立位舒张压显著下降,即在10、35、75和105分钟时,中位数分别下降15.5、11.0、9.5和7.0毫米汞柱,但使用替诺昔康 - 二氮嗪方案时,该血压在任何时间点与基线相比均无显著差异。替诺昔康未改变二氮嗪引起的血糖和血浆胰岛素变化。可能是前列腺素通常有助于降低外周血管阻力,或者急性给予的二氮嗪会增强血管舒张性前列腺素的释放。